Pharvaris N.V. (PHVS) stock
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$33.83−0.35 (-1.02%)
Close on Nov 12, 2026Market cap $2.21BP/E –Yield –
Pharvaris total assets
Total assets on the balance sheet at the end of each period.
Pharvaris's total assets was €328.67M at Jun 30, 2026. For fiscal 2025 it was €301.45M, up 3.5% from the year before. The highest annual figure on record is €398.69M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €301.45M | +3.5% |
| FY2024 | Dec 31, 2024 | €291.37M | -26.9% |
| FY2023 | Dec 31, 2023 | €398.69M | +137.7% |
| FY2022 | Dec 31, 2022 | €167.73M | -20.9% |
| FY2021 | Dec 31, 2021 | €212.09M | +109.8% |
| FY2020 | Dec 31, 2020 | €101.10M | +390.8% |
| FY2019 | Dec 31, 2019 | €20.60M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €328.67M | -6.6% |
| Q4 FY2025 | Dec 31, 2025 | €301.45M | -24.4% |
| Q2 FY2025 | Jun 30, 2025 | €209.81M | +10.6% |
| Q4 FY2024 | Dec 31, 2024 | €291.37M | +73.7% |
| Q2 FY2024 | Jun 30, 2024 | €351.85M | +70.2% |
| Q4 FY2023 | Dec 31, 2023 | €398.69M | +88.0% |
| Q2 FY2023 | Jun 30, 2023 | €189.74M | +87.7% |
| Q4 FY2022 | Dec 31, 2022 | €167.73M | +714.3% |
| Q2 FY2022 | Jun 30, 2022 | €206.74M | – |
| Q4 FY2021 | Dec 31, 2021 | €212.09M | – |
| Q4 FY2020 | Dec 31, 2020 | €101.10M | – |
| Q4 FY2019 | Dec 31, 2019 | €20.60M | – |
See a number that looks wrong?